Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.

I have written several articles on the effects of both cancer and fatigue. One article explained that research shows between ...

Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment ...

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...

Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.